Publications - Kalia Labs

Lorraine V. Kalia

Nim, S, O'Hara, DM, Corbi-Verge, C, Perez-Riba, A, Fujisawa, K, Kapadia, M et al.. Disrupting the α-synuclein-ESCRT interaction with a peptide inhibitor mitigates neurodegeneration in preclinical models of Parkinson's disease. Nat Commun. 2023;14 (1):2150. doi: 10.1038/s41467-023-37464-2. PubMed PMID:37076542 PubMed Central PMC10115881.

McFarthing, K, Bloem, BR, Kalia, LV. People with Parkinson's as Partners for the Journal of Parkinson's Disease. J Parkinsons Dis. 2023;13 (2):125-126. doi: 10.3233/JPD-239000. PubMed PMID:36911950 PubMed Central PMC10041413.

Kalia, LV, Nimmo, GAM, Mestre, TA. Genetic Testing in Clinical Movement Disorders: A Case-Based Review. Semin Neurol. 2023;43 (1):147-155. doi: 10.1055/s-0043-1763507. PubMed PMID:36854393 .

Bloem, BR, Kalia, LV. The Journal of Parkinson's Disease Takes the Open Road. J Parkinsons Dis. 2023;13 (1):1-2. doi: 10.3233/JPD-229011. PubMed PMID:36744347 PubMed Central PMC9912718.

Bloem, BR, Kalia, LV. Thomas G. Beach, MD, PhD, FRCPC, Charles H. Adler, MD, PhD, FAAN, and Simon Stott, PhD, recipients of the Parkinson Prize 2022. J Parkinsons Dis. 2022;12 (8):2283-2286. doi: 10.3233/JPD-229010. PubMed PMID:36565068 .

Huang, Y, Meng, Y, Pople, CB, Bethune, A, Jones, RM, Abrahao, A et al.. Cavitation Feedback Control of Focused Ultrasound Blood-Brain Barrier Opening for Drug Delivery in Patients with Parkinson's Disease. Pharmaceutics. 2022;14 (12):. doi: 10.3390/pharmaceutics14122607. PubMed PMID:36559101 PubMed Central PMC9781334.

Fereshtehnejad, SM, Saleh, PA, Oliveira, LM, Patel, N, Bhowmick, S, Saranza, G et al.. Movement disorders in hereditary spastic paraplegia (HSP): a systematic review and individual participant data meta-analysis. Neurol Sci. 2023;44 (3):947-959. doi: 10.1007/s10072-022-06516-8. PubMed PMID:36441344 PubMed Central PMC9925593.

Kalia, LV. First trials test targeting of α-synuclein for Parkinson disease. Nat Rev Neurol. 2022;18 (12):703-704. doi: 10.1038/s41582-022-00726-6. PubMed PMID:36151474 .

Meng, Y, Pople, CB, Huang, Y, Jones, RM, Ottoy, J, Goubran, M et al.. Putaminal Recombinant Glucocerebrosidase Delivery with Magnetic Resonance-Guided Focused Ultrasound in Parkinson's Disease: A Phase I Study. Mov Disord. 2022;37 (10):2134-2139. doi: 10.1002/mds.29190. PubMed PMID:36089809 .

Ghadery, CM, Kalia, LV, Connolly, BS. Movement disorders of the mouth: a review of the common phenomenologies. J Neurol. 2022;269 (11):5812-5830. doi: 10.1007/s00415-022-11299-1. PubMed PMID:35904592 .

Kalia, LV, Bloem, BR. A New Chapter for the Journal of Parkinson's Disease. J Parkinsons Dis. 2022;12 (5):1365-1367. doi: 10.3233/JPD-229004. PubMed PMID:35811539 .

Sáenz-Farret, M, Lang, AE, Kalia, L, Cunha, I, Sousa, M, Kuhlman, G et al.. Spastic Paraplegia Type 7 and Movement Disorders: Beyond the Spastic Paraplegia. Mov Disord Clin Pract. 2022;9 (4):522-529. doi: 10.1002/mdc3.13437. PubMed PMID:35586535 PubMed Central PMC9092757.

Chen, KS, Menezes, K, Rodgers, JB, O'Hara, DM, Tran, N, Fujisawa, K et al.. Small molecule inhibitors of α-synuclein oligomers identified by targeting early dopamine-mediated motor impairment in C. elegans. Mol Neurodegener. 2021;16 (1):77. doi: 10.1186/s13024-021-00497-6. PubMed PMID:34772429 PubMed Central PMC8588601.

Oliveira, LM, Rastin, T, Nimmo, GAM, Ross, JP, Dion, PA, Zhang, M et al.. Occurrence of Amyotrophic Lateral Sclerosis in Type 1 Gaucher Disease. Neurol Genet. 2021;7 (4):e600. doi: 10.1212/NXG.0000000000000600. PubMed PMID:34017912 PubMed Central PMC8130998.

Barbuti, PA, Barker, RA, Brundin, P, Przedborski, S, Papa, SM, Kalia, LV et al.. Recent Advances in the Development of Stem-Cell-Derived Dopaminergic Neuronal Transplant Therapies for Parkinson's Disease. Mov Disord. 2021;36 (8):1772-1780. doi: 10.1002/mds.28628. PubMed PMID:33963552 .

O'Hara, DM, Kapadia, M, Ping, S, Kalia, SK, Kalia, LV. Semi-Quantitative Determination of Dopaminergic Neuron Density in the Substantia Nigra of Rodent Models using Automated Image Analysis. J Vis Exp. 2021; (168):. doi: 10.3791/62062. PubMed PMID:33616088 .

Bloem, BR, Trenkwalder, C, Sanchez-Ferro, A, Kalia, LV, Alcalay, R, Chiang, HL et al.. COVID-19 Vaccination for Persons with Parkinson's Disease: Light at the End of the Tunnel?. J Parkinsons Dis. 2021;11 (1):3-8. doi: 10.3233/JPD-212573. PubMed PMID:33523021 PubMed Central PMC7990445.

Branfield Day, L, Rajendram, P, Kalia, LV, Gold, WL. An Intelligent Diagnosis: SMART Syndrome. Am J Med. 2021;134 (7):863-865. doi: 10.1016/j.amjmed.2020.11.034. PubMed PMID:33444593 .

Saranza, G, Chen, KS, Ganos, C, Kalia, LV, Chen, R, Lang, AE et al.. Botulinum Toxin-Associated Prolonged Remission of Idiopathic Cervical Dystonia. Can J Neurol Sci. 2021;48 (6):864-868. doi: 10.1017/cjn.2020.280. PubMed PMID:33397526 .

Visanji, NP, Madan, P, Lacoste, AMB, Buleje, I, Han, Y, Spangler, S et al.. Using artificial intelligence to identify anti-hypertensives as possible disease modifying agents in Parkinson's disease. Pharmacoepidemiol Drug Saf. 2021;30 (2):201-209. doi: 10.1002/pds.5176. PubMed PMID:33219601 .

Mylvaganam, S, Earnshaw, R, Heymann, G, Kalia, SK, Kalia, LV. C-terminus of Hsp70 Interacting Protein (CHIP) and Neurodegeneration: Lessons from the Bench and Bedside. Curr Neuropharmacol. 2021;19 (7):1038-1068. doi: 10.2174/1570159X18666201116145507. PubMed PMID:33200713 PubMed Central PMC8686314.

Mukherjee, T, Ramaglia, V, Abdel-Nour, M, Bianchi, AA, Tsalikis, J, Chau, HN et al.. The eIF2α kinase HRI triggers the autophagic clearance of cytosolic protein aggregates. J Biol Chem. 2021;296 :100050. doi: 10.1074/jbc.RA120.014415. PubMed PMID:33168630 PubMed Central PMC7948985.

Kapadia, M, De Snoo, ML, Kalia, LV, Kalia, SK. Regulation of Parkin-dependent mitophagy by Bcl-2-associated athanogene (BAG) family members. Neural Regen Res. 2021;16 (4):684-685. doi: 10.4103/1673-5374.295330. PubMed PMID:33063725 PubMed Central PMC8067924.

Friesen, EL, Zhang, YT, Earnshaw, R, De Snoo, ML, O'Hara, DM, Agapova, V et al.. BAG5 Promotes Alpha-Synuclein Oligomer Formation and Functionally Interacts With the Autophagy Adaptor Protein p62. Front Cell Dev Biol. 2020;8 :716. doi: 10.3389/fcell.2020.00716. PubMed PMID:32850835 PubMed Central PMC7417480.

Meng, Y, Pople, CB, Kalia, SK, Kalia, LV, Davidson, B, Bigioni, L et al.. Cost-effectiveness analysis of MR-guided focused ultrasound thalamotomy for tremor-dominant Parkinson's disease. J Neurosurg. 2020; :1-6. doi: 10.3171/2020.5.JNS20692. PubMed PMID:32764177 .

O'Hara, DM, Pawar, G, Kalia, SK, Kalia, LV. LRRK2 and α-Synuclein: Distinct or Synergistic Players in Parkinson's Disease?. Front Neurosci. 2020;14 :577. doi: 10.3389/fnins.2020.00577. PubMed PMID:32625052 PubMed Central PMC7311858.

Fomenko, A, Lee, DJ, McKinnon, C, Lee, EJ, de Snoo, ML, Gondard, E et al.. Deep Brain Stimulation of the Medial Septal Nucleus Induces Expression of a Virally Delivered Reporter Gene in Dentate Gyrus. Front Neurosci. 2020;14 :463. doi: 10.3389/fnins.2020.00463. PubMed PMID:32477058 PubMed Central PMC7235415.

Maclagan, LC, Visanji, NP, Cheng, Y, Tadrous, M, Lacoste, AMB, Kalia, LV et al.. Identifying drugs with disease-modifying potential in Parkinson's disease using artificial intelligence and pharmacoepidemiology. Pharmacoepidemiol Drug Saf. 2020;29 (8):864-872. doi: 10.1002/pds.5015. PubMed PMID:32410265 .

O'Hara, DM, Kalia, SK, Kalia, LV. Methods for detecting toxic α-synuclein species as a biomarker for Parkinson's disease. Crit Rev Clin Lab Sci. 2020;57 (5):291-307. doi: 10.1080/10408363.2019.1711359. PubMed PMID:32116096 .

Espay, AJ, Kalia, LV, Gan-Or, Z, Williams-Gray, CH, Bedard, PL, Rowe, SM et al.. Disease modification and biomarker development in Parkinson disease: Revision or reconstruction?. Neurology. 2020;94 (11):481-494. doi: 10.1212/WNL.0000000000009107. PubMed PMID:32102975 PubMed Central PMC7220234.

McKinnon, C, De Snoo, ML, Gondard, E, Neudorfer, C, Chau, H, Ngana, SG et al.. Early-onset impairment of the ubiquitin-proteasome system in dopaminergic neurons caused by α-synuclein. Acta Neuropathol Commun. 2020;8 (1):17. doi: 10.1186/s40478-020-0894-0. PubMed PMID:32059750 PubMed Central PMC7023783.

De Snoo, ML, Friesen, EL, Zhang, YT, Earnshaw, R, Dorval, G, Kapadia, M et al.. Bcl-2-associated athanogene 5 (BAG5) regulates Parkin-dependent mitophagy and cell death. Cell Death Dis. 2019;10 (12):907. doi: 10.1038/s41419-019-2132-x. PubMed PMID:31787745 PubMed Central PMC6885512.

Kalia, LV. Expert comment: "A case of missing pathology in a patient with LRRK2 Parkinson's disease". Parkinsonism Relat Disord. 2020;74 :78-79. doi: 10.1016/j.parkreldis.2019.11.005. PubMed PMID:31727562 .

Kalia, LV, Jellinger, KA. Multiple system atrophy and myoclonus: A morphologic marker in the spinal cord?. Neurology. 2019;93 (7):287-288. doi: 10.1212/WNL.0000000000007941. PubMed PMID:31405931 .

Rajalingam, R, Breen, DP, Chen, R, Fox, S, Kalia, LV, Munhoz, RP et al.. The clinical significance of lower limb tremors. Parkinsonism Relat Disord. 2019;65 :165-171. doi: 10.1016/j.parkreldis.2019.06.007. PubMed PMID:31201091 .

McKinnon, C, Gros, P, Lee, DJ, Hamani, C, Lozano, AM, Kalia, LV et al.. Deep brain stimulation: potential for neuroprotection. Ann Clin Transl Neurol. 2019;6 (1):174-185. doi: 10.1002/acn3.682. PubMed PMID:30656196 PubMed Central PMC6331208.

Kalia, LV. Diagnostic biomarkers for Parkinson's disease: focus on α-synuclein in cerebrospinal fluid. Parkinsonism Relat Disord. 2019;59 :21-25. doi: 10.1016/j.parkreldis.2018.11.016. PubMed PMID:30466800 .

Picillo, M, Lizarraga, KJ, Friesen, EL, Chau, H, Zhang, M, Sato, C et al.. Parkinsonism due to A53E α-synuclein gene mutation: Clinical, genetic, epigenetic, and biochemical features. Mov Disord. 2018;33 (12):1950-1955. doi: 10.1002/mds.27506. PubMed PMID:30423204 .

Coakeley, S, Ang, LC, Jansen, GH, Cho, SS, Lang, AE, Houle, S et al.. [¹⁸ F]AV-1451 binding and postmortem pathology of CBD. Mov Disord. 2018;33 (8):1360-1361. doi: 10.1002/mds.27356. PubMed PMID:30136331 .

Ruskey, JA, Zhou, S, Santiago, R, Franche, LA, Alam, A, Roncière, L et al.. The GBA p.Trp378Gly mutation is a probable French-Canadian founder mutation causing Gaucher disease and synucleinopathies. Clin Genet. 2018;94 (3-4):339-345. doi: 10.1111/cge.13405. PubMed PMID:29920646 .

O'Hara, DM, Kalia, SK, Kalia, LV. Emerging disease-modifying strategies targeting α-synuclein for the treatment of Parkinson's disease. Br J Pharmacol. 2018;175 (15):3080-3089. doi: 10.1111/bph.14345. PubMed PMID:29722028 PubMed Central PMC6031880.

Meng, Y, Voisin, MR, Suppiah, S, Kalia, SK, Kalia, LV, Hamani, C et al.. Is there a role for MR-guided focused ultrasound in Parkinson's disease?. Mov Disord. 2018;33 (4):575-579. doi: 10.1002/mds.27308. PubMed PMID:29476631 .

Baskin, B, Kalia, LV, Banwell, BL, Ray, PN, Yoon, G. Complex genomic rearrangement in SPG11 due to a DNA replication-based mechanism. Mov Disord. 2017;32 (12):1792-1794. doi: 10.1002/mds.27188. PubMed PMID:29082553 .

Friesen, EL, De Snoo, ML, Rajendran, L, Kalia, LV, Kalia, SK. Chaperone-Based Therapies for Disease Modification in Parkinson's Disease. Parkinsons Dis. 2017;2017 :5015307. doi: 10.1155/2017/5015307. PubMed PMID:28913005 PubMed Central PMC5585656.

Park, S, Bin, NR, Yu, B, Wong, R, Sitarska, E, Sugita, K et al.. UNC-18 and Tomosyn Antagonistically Control Synaptic Vesicle Priming Downstream of UNC-13 in Caenorhabditis elegans. J Neurosci. 2017;37 (36):8797-8815. doi: 10.1523/JNEUROSCI.0338-17.2017. PubMed PMID:28821673 PubMed Central PMC5588468.

Kalia, LV. Biomarkers for cognitive dysfunction in Parkinson's disease. Parkinsonism Relat Disord. 2018;46 Suppl 1 :S19-S23. doi: 10.1016/j.parkreldis.2017.07.023. PubMed PMID:28781202 .

Koprich, JB, Kalia, LV, Brotchie, JM. Animal models of α-synucleinopathy for Parkinson disease drug development. Nat Rev Neurosci. 2017;18 (9):515-529. doi: 10.1038/nrn.2017.75. PubMed PMID:28747776 .

Rosborough, K, Patel, N, Kalia, LV. α-Synuclein and Parkinsonism: Updates and Future Perspectives. Curr Neurol Neurosci Rep. 2017;17 (4):31. doi: 10.1007/s11910-017-0737-y. PubMed PMID:28324300 .

Breen, DP, Kalia, LV. Exploiting the aggregation properties of alpha-synuclein for diagnostic purposes. Mov Disord. 2017;32 (1):106. doi: 10.1002/mds.26884. PubMed PMID:27896833 .

Visanji, NP, Brotchie, JM, Kalia, LV, Koprich, JB, Tandon, A, Watts, JC et al.. α-Synuclein-Based Animal Models of Parkinson's Disease: Challenges and Opportunities in a New Era. Trends Neurosci. 2016;39 (11):750-762. doi: 10.1016/j.tins.2016.09.003. PubMed PMID:27776749 .

Rowland, NC, Kalia, SK, Kalia, LV, Larson, PS, Lim, DA, Bankiewicz, KS et al.. Merging DBS with viral vector or stem cell implantation: "hybrid" stereotactic surgery as an evolution in the surgical treatment of Parkinson's disease. Mol Ther Methods Clin Dev. 2016;3 :15051. doi: 10.1038/mtm.2015.51. PubMed PMID:26817024 PubMed Central PMC4714520.

Kalia, LV, Lang, AE. Parkinson disease in 2015: Evolving basic, pathological and clinical concepts in PD. Nat Rev Neurol. 2016;12 (2):65-6. doi: 10.1038/nrneurol.2015.249. PubMed PMID:26782330 .

Kalia, LV, Kalia, SK, Lang, AE. Disease-modifying strategies for Parkinson's disease. Mov Disord. 2015;30 (11):1442-50. doi: 10.1002/mds.26354. PubMed PMID:26208210 .

Kalia, LV, Kalia, SK. α-Synuclein and Lewy pathology in Parkinson's disease. Curr Opin Neurol. 2015;28 (4):375-81. doi: 10.1097/WCO.0000000000000215. PubMed PMID:26110807 .

Kalia, LV, Lang, AE. Parkinson's disease. Lancet. 2015;386 (9996):896-912. doi: 10.1016/S0140-6736(14)61393-3. PubMed PMID:25904081 .

Shah, BB, Chen, R, Zurowski, M, Kalia, LV, Gunraj, C, Lang, AE et al.. Repetitive transcranial magnetic stimulation plus standardized suggestion of benefit for functional movement disorders: an open label case series. Parkinsonism Relat Disord. 2015;21 (4):407-12. doi: 10.1016/j.parkreldis.2015.01.013. PubMed PMID:25737204 .

Kalia, LV, Lang, AE, Hazrati, LN, Fujioka, S, Wszolek, ZK, Dickson, DW et al.. Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease. JAMA Neurol. 2015;72 (1):100-5. doi: 10.1001/jamaneurol.2014.2704. PubMed PMID:25401511 PubMed Central PMC4399368.

Kalia, LV, Rockman-Greenberg, C, Borys, A, Lang, AE. Tremor in Spinocerebellar Ataxia Type 12. Mov Disord Clin Pract. 2014;1 (1):76-78. doi: 10.1002/mdc3.12015. PubMed PMID:30363887 PubMed Central PMC6183183.

Beilina, A, Rudenko, IN, Kaganovich, A, Civiero, L, Chau, H, Kalia, SK et al.. Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease. Proc Natl Acad Sci U S A. 2014;111 (7):2626-31. doi: 10.1073/pnas.1318306111. PubMed PMID:24510904 PubMed Central PMC3932908.

Dimant, H, Kalia, SK, Kalia, LV, Zhu, LN, Kibuuka, L, Ebrahimi-Fakhari, D et al.. Direct detection of alpha synuclein oligomers in vivo. Acta Neuropathol Commun. 2013;1 :6. doi: 10.1186/2051-5960-1-6. PubMed PMID:24252244 PubMed Central PMC3776213.

Kalia, LV, Lang, AE, Aviv, RI, Masellis, M. Author response. Neurology. 2013;81 (13):1181. . PubMed PMID:24191352 .

AlDakheel, A, Kalia, LV, Lang, AE. Pathogenesis-targeted, disease-modifying therapies in Parkinson disease. Neurotherapeutics. 2014;11 (1):6-23. doi: 10.1007/s13311-013-0218-1. PubMed PMID:24085420 PubMed Central PMC3899477.

Civardi, C, Collini, A, Kalia, LV, Lang, AE, Aviv, RI, Masellis, M et al.. Hemichorea-hemiballism associated with hyperglycemia and a developmental venous anomaly. Neurology. 2013;81 (13):1181. doi: 10.1212/WNL.0b013e3182a7a945. PubMed PMID:24062343 .

Kalia, LV, Kalia, SK, McLean, PJ, Lozano, AM, Lang, AE. α-Synuclein oligomers and clinical implications for Parkinson disease. Ann Neurol. 2013;73 (2):155-69. doi: 10.1002/ana.23746. PubMed PMID:23225525 PubMed Central PMC3608838.

Kalia, LV, Brotchie, JM, Fox, SH. Novel nondopaminergic targets for motor features of Parkinson's disease: review of recent trials. Mov Disord. 2013;28 (2):131-44. doi: 10.1002/mds.25273. PubMed PMID:23225267 .

Kalia, LV, Mozessohn, L, Aviv, RI, da Costa, L, Lang, AE, Shadowitz, S et al.. Hemichorea-hemiballism associated with hyperglycemia and a developmental venous anomaly. Neurology. 2012;78 (11):838-9. doi: 10.1212/WNL.0b013e318249f733. PubMed PMID:22411959 PubMed Central PMC3304947.

Pitcher, GM, Kalia, LV, Ng, D, Goodfellow, NM, Yee, KT, Lambe, EK et al.. Schizophrenia susceptibility pathway neuregulin 1-ErbB4 suppresses Src upregulation of NMDA receptors. Nat Med. 2011;17 (4):470-8. doi: 10.1038/nm.2315. PubMed PMID:21441918 PubMed Central PMC3264662.

Kalia, LV, Kalia, SK, Chau, H, Lozano, AM, Hyman, BT, McLean, PJ et al.. Ubiquitinylation of α-synuclein by carboxyl terminus Hsp70-interacting protein (CHIP) is regulated by Bcl-2-associated athanogene 5 (BAG5). PLoS One. 2011;6 (2):e14695. doi: 10.1371/journal.pone.0014695. PubMed PMID:21358815 PubMed Central PMC3040167.

Kalia, SK, Kalia, LV, McLean, PJ. Molecular chaperones as rational drug targets for Parkinson's disease therapeutics. CNS Neurol Disord Drug Targets. 2010;9 (6):741-53. doi: 10.2174/187152710793237386. PubMed PMID:20942788 PubMed Central PMC3364514.

Kalia, LV, Lee, L, Kalia, SK, Pirouzmand, F, Rapoport, MJ, Aviv, RI et al.. Thoracic myelopathy from coincident fluorosis and epidural lipomatosis. Can J Neurol Sci. 2010;37 (2):276-8. doi: 10.1017/s0317167100010076. PubMed PMID:20437944 .

Ng, D, Pitcher, GM, Szilard, RK, Sertié, A, Kanisek, M, Clapcote, SJ et al.. Neto1 is a novel CUB-domain NMDA receptor-interacting protein required for synaptic plasticity and learning. PLoS Biol. 2009;7 (2):e41. doi: 10.1371/journal.pbio.1000041. PubMed PMID:19243221 PubMed Central PMC2652390.

Kalia, LV, Kalia, SK, Salter, MW. NMDA receptors in clinical neurology: excitatory times ahead. Lancet Neurol. 2008;7 (8):742-55. doi: 10.1016/S1474-4422(08)70165-0. PubMed PMID:18635022 PubMed Central PMC3589564.

Kalia, LV, Pitcher, GM, Pelkey, KA, Salter, MW. PSD-95 is a negative regulator of the tyrosine kinase Src in the NMDA receptor complex. EMBO J. 2006;25 (20):4971-82. doi: 10.1038/sj.emboj.7601342. PubMed PMID:16990796 PubMed Central PMC1618112.

Kalia, LV, O'Connor, PW. Severity of chronic pain and its relationship to quality of life in multiple sclerosis. Mult Scler. 2005;11 (3):322-7. doi: 10.1191/1352458505ms1168oa. PubMed PMID:15957515 .

Kalia, LV, Gingrich, JR, Salter, MW. Src in synaptic transmission and plasticity. Oncogene. 2004;23 (48):8007-16. doi: 10.1038/sj.onc.1208158. PubMed PMID:15489918 .

Salter, MW, Kalia, LV. Src kinases: a hub for NMDA receptor regulation. Nat Rev Neurosci. 2004;5 (4):317-28. doi: 10.1038/nrn1368. PubMed PMID:15034556 .

Kalia, LV, Salter, MW. Interactions between Src family protein tyrosine kinases and PSD-95. Neuropharmacology. 2003;45 (6):720-8. doi: 10.1016/s0028-3908(03)00313-7. PubMed PMID:14529711 .

Fam, SR, Gallagher, CJ, Kalia, LV, Salter, MW. Differential frequency dependence of P2Y1- and P2Y2- mediated Ca 2+ signaling in astrocytes. J Neurosci. 2003;23 (11):4437-44. doi: 10.1523/JNEUROSCI.23-11-04437.2003. PubMed PMID:12805284 PubMed Central PMC6740798.

Kalia, LV. Barriers to women clinician-scientists: a trainee's perspective. Clin Invest Med. 2003;26 (1):15-6. . PubMed PMID:12659464 .

Nong, Y, Huang, YQ, Ju, W, Kalia, LV, Ahmadian, G, Wang, YT et al.. Glycine binding primes NMDA receptor internalization. Nature. 2003;422 (6929):302-7. doi: 10.1038/nature01497. PubMed PMID:12646920 .

Pelkey, KA, Askalan, R, Paul, S, Kalia, LV, Nguyen, TH, Pitcher, GM et al.. Tyrosine phosphatase STEP is a tonic brake on induction of long-term potentiation. Neuron. 2002;34 (1):127-38. doi: 10.1016/s0896-6273(02)00633-5. PubMed PMID:11931747 .

Regan, D, Hajdur, LV, Hong, XH. Two-dimensional aspect ratio discrimination for shape defined by orientation texture. Vision Res. 1996;36 (22):3695-702. doi: 10.1016/0042-6989(96)00083-1. PubMed PMID:8976999 .

Search PubMed

Suneil K. Kalia

Basha, D, Kalia, SK, Hodaie, M, Lopez Rios, AL, Lozano, AM, Hutchison, WD et al.. Beta band oscillations in the motor thalamus are modulated by visuomotor coordination in essential tremor patients. Front Hum Neurosci. 2023;17 :1082196. doi: 10.3389/fnhum.2023.1082196. PubMed PMID:37180551 PubMed Central PMC10169705.

Tian, Y, Murphy, MJH, Steiner, LA, Kalia, SK, Hodaie, M, Lozano, AM et al.. Modeling Instantaneous Firing Rate of Deep Brain Stimulation Target Neuronal Ensembles in the Basal Ganglia and Thalamus. Neuromodulation. 2023; :. doi: 10.1016/j.neurom.2023.03.012. PubMed PMID:37140523 .

Alanazi, FI, Kalia, SK, Hodaie, M, Lopez Rios, AL, Lozano, AM, Milosevic, L et al.. Top-down control of human motor thalamic neuronal activity during the auditory oddball task. NPJ Parkinsons Dis. 2023;9 (1):46. doi: 10.1038/s41531-023-00493-1. PubMed PMID:36973276 PubMed Central PMC10042852.

Balachandar, A, Boutet, A, Vetkas, A, Germann, J, Chan, IYM, Mikulis, D et al.. Reply to: Glioblastoma, IDH-Wildtype, CNS WHO Grade 4, Associated with Deep Brain Stimulation in a Patient with Essential Tremor: Report of a Case with Molecular Characterization and Review of the Literature. Mov Disord Clin Pract. 2023;10 (3):529-530. doi: 10.1002/mdc3.13673. PubMed PMID:36949794 PubMed Central PMC10026296.

Balachandar, A, Boutet, A, Vetkas, A, Germann, J, Chan, IYM, Mikulis, D et al.. The Role of Safe MRI in Diagnosing an Unusual Case of High-Grade Glioma Adjacent to Globus Pallidus Interna DBS Electrode. Mov Disord Clin Pract. 2023;10 (1):138-140. doi: 10.1002/mdc3.13574. PubMed PMID:36704068 PubMed Central PMC9847298.

Vetkas, A, Germann, J, Boutet, A, Samuel, N, Sarica, C, Yamamoto, K et al.. Laser interstitial thermal therapy for the treatment of insular lesions: A systematic review. Front Neurol. 2022;13 :1024075. doi: 10.3389/fneur.2022.1024075. PubMed PMID:36686528 PubMed Central PMC9845884.

Darmani, G, Drummond, NM, Ramezanpour, H, Saha, U, Hoque, T, Udupa, K et al.. Long-Term Recording of Subthalamic Aperiodic Activities and Beta Bursts in Parkinson's Disease. Mov Disord. 2023;38 (2):232-243. doi: 10.1002/mds.29276. PubMed PMID:36424835 .

Cheyuo, C, Germann, J, Yamamoto, K, Vetkas, A, Loh, A, Sarica, C et al.. Connectomic neuromodulation for Alzheimer's disease: A systematic review and meta-analysis of invasive and non-invasive techniques. Transl Psychiatry. 2022;12 (1):490. doi: 10.1038/s41398-022-02246-9. PubMed PMID:36411282 PubMed Central PMC9678946.

O'Halloran, PJ, Henry, J, Amoo, M, Kalyvas, A, Mohan, N, Zadeh, G et al.. LITTing up Gliomas-Is the Future Bright?. World Neurosurg X. 2023;17 :100136. doi: 10.1016/j.wnsx.2022.100136. PubMed PMID:36267388 PubMed Central PMC9576579.

Steiner, LA, Kühn, AA, Geiger, JR, Alle, H, Popovic, MR, Kalia, SK et al.. Persistent synaptic inhibition of the subthalamic nucleus by high frequency stimulation. Brain Stimul. 2022;15 (5):1223-1232. doi: 10.1016/j.brs.2022.08.020. PubMed PMID:36058524 .

Scherer, M, Steiner, LA, Kalia, SK, Hodaie, M, Kühn, AA, Lozano, AM et al.. Single-neuron bursts encode pathological oscillations in subcortical nuclei of patients with Parkinson's disease and essential tremor. Proc Natl Acad Sci U S A. 2022;119 (35):e2205881119. doi: 10.1073/pnas.2205881119. PubMed PMID:36018837 PubMed Central PMC9436336.

Warsi, NM, Yan, H, Wong, SM, Yau, I, Breitbart, S, Go, C et al.. Vagus Nerve Stimulation Modulates Phase-Amplitude Coupling in Thalamic Local Field Potentials. Neuromodulation. 2023;26 (3):601-606. doi: 10.1016/j.neurom.2022.05.001. PubMed PMID:35840521 .

Potel, SR, Marceglia, S, Meoni, S, Kalia, SK, Cury, RG, Moro, E et al.. Advances in DBS Technology and Novel Applications: Focus on Movement Disorders. Curr Neurol Neurosci Rep. 2022;22 (9):577-588. doi: 10.1007/s11910-022-01221-7. PubMed PMID:35838898 .

Loh, A, Boutet, A, Germann, J, Al-Fatly, B, Elias, GJB, Neudorfer, C et al.. A Functional Connectome of Parkinson's Disease Patients Prior to Deep Brain Stimulation: A Tool for Disease-Specific Connectivity Analyses. Front Neurosci. 2022;16 :804125. doi: 10.3389/fnins.2022.804125. PubMed PMID:35812235 PubMed Central PMC9263841.

Loh, A, Elias, GJB, Germann, J, Boutet, A, Gwun, D, Yamamoto, K et al.. Neural Correlates of Optimal Deep Brain Stimulation for Cervical Dystonia. Ann Neurol. 2022;92 (3):418-424. doi: 10.1002/ana.26450. PubMed PMID:35785489 .

Katz, CN, Schjetnan, AGP, Patel, K, Barkley, V, Hoffman, KL, Kalia, SK et al.. A corollary discharge mediates saccade-related inhibition of single units in mnemonic structures of the human brain. Curr Biol. 2022;32 (14):3082-3094.e4. doi: 10.1016/j.cub.2022.06.015. PubMed PMID:35779529 .

Milosevic, L, Sumarac, S, Di Luca, DG, Ramirez-Gomez, C, Hodaie, M, Hutchison, WD et al.. Pallidal neuronal activity in multiple system atrophy type P and Parkinson's disease. Parkinsonism Relat Disord. 2022;101 :15-17. doi: 10.1016/j.parkreldis.2022.06.007. PubMed PMID:35753144 .

Vetkas, A, Germann, J, Elias, G, Loh, A, Boutet, A, Yamamoto, K et al.. Identifying the neural network for neuromodulation in epilepsy through connectomics and graphs. Brain Commun. 2022;4 (3):fcac092. doi: 10.1093/braincomms/fcac092. PubMed PMID:35611305 PubMed Central PMC9123846.

Vetkas, A, Fomenko, A, Germann, J, Sarica, C, Iorio-Morin, C, Samuel, N et al.. Response: Deep brain stimulation targets in epilepsy: Systematic review and meta-analysis of anterior and centromedian thalamic nuclei and hippocampus. Epilepsia. 2022;63 (7):1885-1886. doi: 10.1111/epi.17272. PubMed PMID:35514031 .

Zheng, J, Schjetnan, AGP, Yebra, M, Gomes, BA, Mosher, CP, Kalia, SK et al.. Neurons detect cognitive boundaries to structure episodic memories in humans. Nat Neurosci. 2022;25 (3):358-368. doi: 10.1038/s41593-022-01020-w. PubMed PMID:35260859 PubMed Central PMC8966433.

Lizárraga, KJ, Gnanamanogaran, B, Al-Ozzi, TM, Cohn, M, Tomlinson, G, Boutet, A et al.. Lateralized Subthalamic Stimulation for Axial Dysfunction in Parkinson's Disease: A Randomized Trial. Mov Disord. 2022;37 (5):1079-1087. doi: 10.1002/mds.28953. PubMed PMID:35156734 .

Fasano, A, Gorodetsky, C, Paul, D, Germann, J, Loh, A, Yan, H et al.. Local Field Potential-Based Programming: A Proof-of-Concept Pilot Study. Neuromodulation. 2022;25 (2):271-275. doi: 10.1111/ner.13520. PubMed PMID:35125146 .

Huo, M, Rose, M, van Prooijen, M, Cusimano, MD, Laperriere, N, Heaton, R et al.. Importance of Cobalt-60 Dose Rate and Biologically Effective Dose on Local Control for Intracranial Meningiomas Treated With Stereotactic Radiosurgery. Neurosurgery. 2022;90 (1):140-147. doi: 10.1227/NEU.0000000000001755. PubMed PMID:34982881 .

Vetkas, A, Fomenko, A, Germann, J, Sarica, C, Iorio-Morin, C, Samuel, N et al.. Deep brain stimulation targets in epilepsy: Systematic review and meta-analysis of anterior and centromedian thalamic nuclei and hippocampus. Epilepsia. 2022;63 (3):513-524. doi: 10.1111/epi.17157. PubMed PMID:34981509 .

Samuel, N, Vetkas, A, Pancholi, A, Sarica, C, Loh, A, Germann, J et al.. A Network-Based Approach to Glioma Surgery: Insights from Functional Neurosurgery. Cancers (Basel). 2021;13 (23):. doi: 10.3390/cancers13236127. PubMed PMID:34885236 PubMed Central PMC8656669.

Habets, JGV, Herff, C, Fasano, AA, Beudel, M, Kocabicak, E, Schnitzler, A et al.. Multicenter Validation of Individual Preoperative Motor Outcome Prediction for Deep Brain Stimulation in Parkinson's Disease. Stereotact Funct Neurosurg. 2022;100 (2):121-129. doi: 10.1159/000519960. PubMed PMID:34823246 .

Sasikumar, S, Cohn, M, Harmsen, IE, Loh, A, Cho, SS, Sáenz-Farret, M et al.. Single-Trajectory Multiple-Target Deep Brain Stimulation for Parkinsonian Mobility and Cognition. Mov Disord. 2022;37 (3):635-640. doi: 10.1002/mds.28870. PubMed PMID:34806782 .

Torlakcik, H, Sarica, C, Bayer, P, Yamamoto, K, Iorio-Morin, C, Hodaie, M et al.. Magnetically Guided Catheters, Micro- and Nanorobots for Spinal Cord Stimulation. Front Neurorobot. 2021;15 :749024. doi: 10.3389/fnbot.2021.749024. PubMed PMID:34744678 PubMed Central PMC8565609.

Patel, K, Katz, CN, Kalia, SK, Popovic, MR, Valiante, TA. Volitional control of individual neurons in the human brain. Brain. 2021;144 (12):3651-3663. doi: 10.1093/brain/awab370. PubMed PMID:34623400 PubMed Central PMC8719845.

Visanji, NP, Ghani, M, Yu, E, Kakhki, EG, Sato, C, Moreno, D et al.. Axial Impairment Following Deep Brain Stimulation in Parkinson's Disease: A Surgicogenomic Approach. J Parkinsons Dis. 2022;12 (1):117-128. doi: 10.3233/JPD-212730. PubMed PMID:34602499 PubMed Central PMC8842751.

Sarica, C, Iorio-Morin, C, Aguirre-Padilla, DH, Najjar, A, Paff, M, Fomenko, A et al.. Implantable Pulse Generators for Deep Brain Stimulation: Challenges, Complications, and Strategies for Practicality and Longevity. Front Hum Neurosci. 2021;15 :708481. doi: 10.3389/fnhum.2021.708481. PubMed PMID:34512295 PubMed Central PMC8427803.

Iwasa, SN, Shi, HH, Hong, SH, Chen, T, Marquez-Chin, M, Iorio-Morin, C et al.. Novel Electrode Designs for Neurostimulation in Regenerative Medicine: Activation of Stem Cells. Bioelectricity. 2020;2 (4):348-361. doi: 10.1089/bioe.2020.0034. PubMed PMID:34471854 PubMed Central PMC8370381.

Alanazi, FI, Al-Ozzi, TM, Kalia, SK, Hodaie, M, Lozano, AM, Cohn, M et al.. Neurophysiological responses of globus pallidus internus during the auditory oddball task in Parkinson's disease. Neurobiol Dis. 2021;159 :105490. doi: 10.1016/j.nbd.2021.105490. PubMed PMID:34461266 .

Maciel, R, Soh, D, Munhoz, RP, Poon, YY, Kalia, SK, Hodaie, M et al.. Programming Directional Deep Brain Stimulation in Parkinson's Disease: A Randomized Prospective Trial Comparing Early versus Delayed Stimulation Steering. Stereotact Funct Neurosurg. 2021;99 (6):484-490. doi: 10.1159/000517054. PubMed PMID:34350897 .

Iorio-Morin, C, Yamamoto, K, Sarica, C, Zemmar, A, Levesque, M, Brisebois, S et al.. Bilateral Focused Ultrasound Thalamotomy for Essential Tremor (BEST-FUS Phase 2 Trial). Mov Disord. 2021;36 (11):2653-2662. doi: 10.1002/mds.28716. PubMed PMID:34288097 .

Soh, D, Maciel, R, Algarni, M, Lizarraga, K, Loh, A, Germann, J et al.. Flexible vs. standard subthalamic stimulation in Parkinson disease: A double-blind proof-of-concept cross-over trial. Parkinsonism Relat Disord. 2021;89 :93-97. doi: 10.1016/j.parkreldis.2021.07.003. PubMed PMID:34271424 .

Sarica, C, Yamamoto, K, Loh, A, Elias, GJB, Boutet, A, Madhavan, R et al.. Blood oxygen level-dependent (BOLD) response patterns with thalamic deep brain stimulation in patients with medically refractory epilepsy. Epilepsy Behav. 2021;122 :108153. doi: 10.1016/j.yebeh.2021.108153. PubMed PMID:34153639 .

Villafuerte, CJ, Shultz, DB, Laperriere, N, Gentili, F, Heaton, R, van Prooijen, M et al.. Radiation Dose Rate, Biologically Effective Dose, and Tumor Characteristics on Local Control and Toxicity After Radiosurgery for Acoustic Neuromas. World Neurosurg. 2021;152 :e512-e522. doi: 10.1016/j.wneu.2021.05.122. PubMed PMID:34098139 .

Zeng, K, Drummond, NM, Ghahremani, A, Saha, U, Kalia, SK, Hodaie, M et al.. Fronto-subthalamic phase synchronization and cross-frequency coupling during conflict processing. Neuroimage. 2021;238 :118205. doi: 10.1016/j.neuroimage.2021.118205. PubMed PMID:34077804 PubMed Central PMC8944202.

Boutet, A, Madhavan, R, Elias, GJB, Joel, SE, Gramer, R, Ranjan, M et al.. Predicting optimal deep brain stimulation parameters for Parkinson's disease using functional MRI and machine learning. Nat Commun. 2021;12 (1):3043. doi: 10.1038/s41467-021-23311-9. PubMed PMID:34031407 PubMed Central PMC8144408.

Milosevic, L, Kalia, SK, Hodaie, M, Lozano, AM, Popovic, MR, Hutchison, WD et al.. A theoretical framework for the site-specific and frequency-dependent neuronal effects of deep brain stimulation. Brain Stimul. 2021;14 (4):807-821. doi: 10.1016/j.brs.2021.04.022. PubMed PMID:33991712 .

Lee, DJ, Drummond, NM, Saha, U, De Vloo, P, Dallapiazza, RF, Gramer, R et al.. Acute low frequency dorsal subthalamic nucleus stimulation improves verbal fluency in Parkinson's disease. Brain Stimul. 2021;14 (4):754-760. doi: 10.1016/j.brs.2021.04.016. PubMed PMID:33940243 .

Boutet, A, Germann, J, Gwun, D, Loh, A, Elias, GJB, Neudorfer, C et al.. Sign-specific stimulation 'hot' and 'cold' spots in Parkinson's disease validated with machine learning. Brain Commun. 2021;3 (2):fcab027. doi: 10.1093/braincomms/fcab027. PubMed PMID:33870190 PubMed Central PMC8042250.

Oliveira, LM, Ruiz-Lopez, M, Boutet, A, Elias, GJB, Kalia, SK, Hodaie, M et al.. Self-adjustment of deep brain stimulation delays optimization in Parkinson's disease. Brain Stimul. 2021;14 (3):676-681. doi: 10.1016/j.brs.2021.04.001. PubMed PMID:33852934 .

Warsi, NM, Farb, RI, Kalia, SK. Spinal Longitudinal Epidural Collections in Intracranial Hypotension. Can J Neurol Sci. 2022;49 (2):272-273. doi: 10.1017/cjn.2021.58. PubMed PMID:33818333 .

Sasikumar, S, Matta, R, Munhoz, RP, Zurowski, M, Poon, YY, Hodaie, M et al.. Advanced Therapies for the Management of Dopamine Dysregulation Syndrome in Parkinson's Disease. Mov Disord Clin Pract. 2021;8 (3):400-405. doi: 10.1002/mdc3.13154. PubMed PMID:33816669 PubMed Central PMC8015898.

Boutet, A, Loh, A, Chow, CT, Taha, A, Elias, GJB, Neudorfer, C et al.. A literature review of magnetic resonance imaging sequence advancements in visualizing functional neurosurgery targets. J Neurosurg. 2021; :1-14. doi: 10.3171/2020.8.JNS201125. PubMed PMID:33770759 .

Sáenz-Farret, M, Loh, A, Boutet, A, Germann, J, Elias, GJB, Kalia, SK et al.. Theta Burst Deep Brain Stimulation in Movement Disorders. Mov Disord Clin Pract. 2021;8 (2):282-285. doi: 10.1002/mdc3.13130. PubMed PMID:33681412 PubMed Central PMC7906022.

M Oliveira, L, Yan, H, Algarni, M, J B Elias, G, Germann, J, Boutet, A et al.. Probabilistic characterisation of deep brain stimulation in patients with tardive syndromes. J Neurol Neurosurg Psychiatry. 2021; :. doi: 10.1136/jnnp-2020-324270. PubMed PMID:33563812 .

Coblentz, A, Elias, GJB, Boutet, A, Germann, J, Algarni, M, Oliveira, LM et al.. Mapping efficacious deep brain stimulation for pediatric dystonia. J Neurosurg Pediatr. 2021;27 (3):346-356. doi: 10.3171/2020.7.PEDS20322. PubMed PMID:33385998 .

Iorio-Morin, C, Fomenko, A, Kalia, SK. Deep-Brain Stimulation for Essential Tremor and Other Tremor Syndromes: A Narrative Review of Current Targets and Clinical Outcomes. Brain Sci. 2020;10 (12):. doi: 10.3390/brainsci10120925. PubMed PMID:33271848 PubMed Central PMC7761254.

Elias, GJB, Boutet, A, Joel, SE, Germann, J, Gwun, D, Neudorfer, C et al.. Probabilistic Mapping of Deep Brain Stimulation: Insights from 15 Years of Therapy. Ann Neurol. 2021;89 (3):426-443. doi: 10.1002/ana.25975. PubMed PMID:33252146 .

Picillo, M, Phokaewvarangkul, O, Poon, YY, McIntyre, CC, Beylergil, SB, Munhoz, RP et al.. Levodopa Versus Dopamine Agonist after Subthalamic Stimulation in Parkinson's Disease. Mov Disord. 2021;36 (3):672-680. doi: 10.1002/mds.28382. PubMed PMID:33165964 PubMed Central PMC8048876.

Gasim, M, Kalia, SK, Hodaie, M, Lozano, AM, Venkatraghavan, L, Hutchison, WD et al.. The Association of Dexmedetomidine with Firing Properties in Pallidal Neurons. Can J Neurol Sci. 2021;48 (4):525-533. doi: 10.1017/cjn.2020.243. PubMed PMID:33148354 .

Coulter, IC, Yan, H, Gorodetsky, C, Akhbari, M, Breitbart, S, Kalia, SK et al.. Childhood choreoathetosis secondary to hyper-IgM syndrome (CD40 ligand deficiency). Neurol Neuroimmunol Neuroinflamm. 2020;7 (6):. doi: 10.1212/NXI.0000000000000899. PubMed PMID:33067350 PubMed Central PMC7577528.

De Vloo, P, Milosevic, L, Gramer, RM, Dallapiazza, RF, Lee, DJ, Fasano, A et al.. Microelectrode Recording and Radiofrequency Thalamotomy following Focused Ultrasound Thalamotomy. Stereotact Funct Neurosurg. 2021;99 (1):34-37. doi: 10.1159/000510109. PubMed PMID:32937628 .

Yan, H, Siegel, L, Breitbart, S, Gorodetsky, C, Gonorazky, HD, Yau, I et al.. The Child & Youth CompreHensIve Longitudinal Database for Deep Brain Stimulation (CHILD-DBS). Childs Nerv Syst. 2021;37 (2):607-615. doi: 10.1007/s00381-020-04880-4. PubMed PMID:32935233 .

Milosevic, L, De Vloo, P, Gramer, R, Kalia, SK, Fasano, A, Popovic, MR et al.. Neuronal Activity and Synaptic Plasticity in a Reimplanted STN-DBS Patient with Parkinson's Disease: Recordings from Two Surgeries. Stereotact Funct Neurosurg. 2020;98 (3):206-212. doi: 10.1159/000505705. PubMed PMID:32294659 .

Chandravadia, N, Liang, D, Schjetnan, AGP, Carlson, A, Faraut, M, Chung, JM et al.. A NWB-based dataset and processing pipeline of human single-neuron activity during a declarative memory task. Sci Data. 2020;7 (1):78. doi: 10.1038/s41597-020-0415-9. PubMed PMID:32132545 PubMed Central PMC7055261.

Boutet, A, Elias, GJB, Gramer, R, Neudorfer, C, Germann, J, Naheed, A et al.. Safety assessment of spine MRI in deep brain stimulation patients. J Neurosurg Spine. 2020; :1-11. doi: 10.3171/2019.12.SPINE191241. PubMed PMID:32059193 .

Yan, H, Boutet, A, Mithani, K, Germann, J, Elias, GJB, Yau, I et al.. Aggressiveness after centromedian nucleus stimulation engages prefrontal thalamocortical circuitry. Brain Stimul. 2020;13 (2):357-359. doi: 10.1016/j.brs.2019.10.023. PubMed PMID:31727583 .

Ruiz-Lopez, M, Munhoz, RP, Kalia, SK, Zorzi, G, Nardocci, N, Fasano, A et al.. Status dystonicus induced by deep brain stimulation surgery. Neurol Sci. 2020;41 (3):729-730. doi: 10.1007/s10072-019-04083-z. PubMed PMID:31628618 .

Grimes, D, Fitzpatrick, M, Gordon, J, Miyasaki, J, Fon, EA, Schlossmacher, M et al.. Canadian guideline for Parkinson disease. CMAJ. 2019;191 (36):E989-E1004. doi: 10.1503/cmaj.181504. PubMed PMID:31501181 PubMed Central PMC6733687.

Picillo, M, Paramanandam, V, Morgante, F, Algarni, M, Olszewska, DA, Munhoz, RP et al.. Dystonia as complication of thalamic neurosurgery. Parkinsonism Relat Disord. 2019;66 :232-236. doi: 10.1016/j.parkreldis.2019.08.008. PubMed PMID:31434632 .

Milosevic, L, Kalia, SK, Hodaie, M, Lozano, A, Popovic, MR, Hutchison, W et al.. Subthalamic suppression defines therapeutic threshold of deep brain stimulation in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2019;90 (10):1105-1108. doi: 10.1136/jnnp-2019-321140. PubMed PMID:31422369 .

Milosevic, L, Dallapiazza, RF, Munhoz, RP, Kalia, SK, Popovic, MR, Hutchison, WD et al.. Case Studies in Neuroscience: Lack of inhibitory synaptic plasticity in the substantia nigra pars reticulata of a patient with lithium-induced tremor. J Neurophysiol. 2019;122 (4):1367-1372. doi: 10.1152/jn.00203.2019. PubMed PMID:31411948 PubMed Central PMC6843100.

Boutet, A, Rashid, T, Hancu, I, Elias, GJB, Gramer, RM, Germann, J et al.. Functional MRI Safety and Artifacts during Deep Brain Stimulation: Experience in 102 Patients. Radiology. 2019;293 (1):174-183. doi: 10.1148/radiol.2019190546. PubMed PMID:31385756 .

Badhiwala, JH, Karmur, B, Elkaim, LM, Alotaibi, NM, Morgan, BR, Lipsman, N et al.. Clinical phenotypes associated with outcomes following deep brain stimulation for childhood dystonia. J Neurosurg Pediatr. 2019; :1-9. doi: 10.3171/2019.5.PEDS1973. PubMed PMID:31299640 .

Bally, JF, Rohani, M, Ruiz-Lopez, M, Paramanandam, V, Munhoz, RP, Hodaie, M et al.. Patient-adjusted deep-brain stimulation programming is time saving in dystonia patients. J Neurol. 2019;266 (10):2423-2429. doi: 10.1007/s00415-019-09423-9. PubMed PMID:31197514 .

Lee, EJ, Kalia, SK, Hong, SH. A Primer on Magnetic Resonance-Guided Laser Interstitial Thermal Therapy for Medically Refractory Epilepsy. J Korean Neurosurg Soc. 2019;62 (3):353-360. doi: 10.3340/jkns.2019.0105. PubMed PMID:31085962 PubMed Central PMC6514321.

Lee, DJ, Milosevic, L, Gramer, R, Sasikumar, S, Al-Ozzi, TM, De Vloo, P et al.. Nucleus basalis of Meynert neuronal activity in Parkinson's disease. J Neurosurg. 2019;132 (2):574-582. doi: 10.3171/2018.11.JNS182386. PubMed PMID:30797189 .

De Vloo, P, Reddy, GD, Rowland, N, Sammartino, F, Llinas, M, Paul, D et al.. Successful spinal cord stimulation for severe medication-refractory restless legs syndrome. Mov Disord. 2019;34 (4):585-586. doi: 10.1002/mds.27644. PubMed PMID:30768799 .

Gondard, E, Teves, L, Wang, L, McKinnon, C, Hamani, C, Kalia, SK et al.. Deep Brain Stimulation Rescues Memory and Synaptic Activity in a Rat Model of Global Ischemia. J Neurosci. 2019;39 (13):2430-2440. doi: 10.1523/JNEUROSCI.1222-18.2019. PubMed PMID:30696731 PubMed Central PMC6435818.

De Vloo, P, Lee, DJ, Dallapiazza, RF, Rohani, M, Fasano, A, Munhoz, RP et al.. Deep brain stimulation for pantothenate kinase-associated neurodegeneration: A meta-analysis. Mov Disord. 2019;34 (2):264-273. doi: 10.1002/mds.27563. PubMed PMID:30633810 .

Hancu, I, Boutet, A, Fiveland, E, Ranjan, M, Prusik, J, Dimarzio, M et al.. On the (Non-)equivalency of monopolar and bipolar settings for deep brain stimulation fMRI studies of Parkinson's disease patients. J Magn Reson Imaging. 2019;49 (6):1736-1749. doi: 10.1002/jmri.26321. PubMed PMID:30552842 .

Yan, H, Toyota, E, Anderson, M, Abel, TJ, Donner, E, Kalia, SK et al.. A systematic review of deep brain stimulation for the treatment of drug-resistant epilepsy in childhood. J Neurosurg Pediatr. 2018;23 (3):274-284. doi: 10.3171/2018.9.PEDS18417. PubMed PMID:30544364 .

Coulombe, MA, Elkaim, LM, Alotaibi, NM, Gorman, DA, Weil, AG, Fallah, A et al.. Deep brain stimulation for Gilles de la Tourette syndrome in children and youth: a meta-analysis with individual participant data. J Neurosurg Pediatr. 2018;23 (2):236-246. doi: 10.3171/2018.7.PEDS18300. PubMed PMID:30497215 .

Harmsen, IE, Lee, DJ, Dallapiazza, RF, De Vloo, P, Chen, R, Fasano, A et al.. Ultra-high-frequency deep brain stimulation at 10,000 Hz improves motor function. Mov Disord. 2019;34 (1):146-148. doi: 10.1002/mds.27550. PubMed PMID:30423217 .

Milosevic, L, Gramer, R, Kim, TH, Algarni, M, Fasano, A, Kalia, SK et al.. Modulation of inhibitory plasticity in basal ganglia output nuclei of patients with Parkinson's disease. Neurobiol Dis. 2019;124 :46-56. doi: 10.1016/j.nbd.2018.10.020. PubMed PMID:30391540 .

Dallapiazza, RF, Lee, DJ, De Vloo, P, Fomenko, A, Hamani, C, Hodaie, M et al.. Outcomes from stereotactic surgery for essential tremor. J Neurol Neurosurg Psychiatry. 2019;90 (4):474-482. doi: 10.1136/jnnp-2018-318240. PubMed PMID:30337440 PubMed Central PMC6581115.

Elkaim, LM, Alotaibi, NM, Sigal, A, Alotaibi, HM, Lipsman, N, Kalia, SK et al.. Deep brain stimulation for pediatric dystonia: a meta-analysis with individual participant data. Dev Med Child Neurol. 2019;61 (1):49-56. doi: 10.1111/dmcn.14063. PubMed PMID:30320439 .

Elkaim, LM, De Vloo, P, Kalia, SK, Lozano, AM, Ibrahim, GM. Deep brain stimulation for childhood dystonia: current evidence and emerging practice. Expert Rev Neurother. 2018;18 (10):773-784. doi: 10.1080/14737175.2018.1523721. PubMed PMID:30221558 .

Fomenko, A, Neudorfer, C, Dallapiazza, RF, Kalia, SK, Lozano, AM. Low-intensity ultrasound neuromodulation: An overview of mechanisms and emerging human applications. Brain Stimul. 2018;11 (6):1209-1217. doi: 10.1016/j.brs.2018.08.013. PubMed PMID:30166265 .

Ghahremani, A, Aron, AR, Udupa, K, Saha, U, Reddy, D, Hutchison, WD et al.. Event-related deep brain stimulation of the subthalamic nucleus affects conflict processing. Ann Neurol. 2018;84 (4):515-526. doi: 10.1002/ana.25312. PubMed PMID:30152889 PubMed Central PMC6431255.

Milosevic, L, Kalia, SK, Hodaie, M, Lozano, AM, Popovic, MR, Hutchison, WD et al.. Physiological mechanisms of thalamic ventral intermediate nucleus stimulation for tremor suppression. Brain. 2018;141 (7):2142-2155. doi: 10.1093/brain/awy139. PubMed PMID:29878147 PubMed Central PMC6022553.

Cury, RG, Kalia, SK, Shah, BB, Jimenez-Shahed, J, Prashanth, LK, Moro, E et al.. Surgical treatment of dystonia. Expert Rev Neurother. 2018;18 (6):477-492. doi: 10.1080/14737175.2018.1478288. PubMed PMID:29781334 .

Ni, Z, Kim, SJ, Phielipp, N, Ghosh, S, Udupa, K, Gunraj, CA et al.. Pallidal deep brain stimulation modulates cortical excitability and plasticity. Ann Neurol. 2018;83 (2):352-362. doi: 10.1002/ana.25156. PubMed PMID:29369401 .

Mann, A, Gondard, E, Tampellini, D, Milsted, JAT, Marillac, D, Hamani, C et al.. Chronic deep brain stimulation in an Alzheimer's disease mouse model enhances memory and reduces pathological hallmarks. Brain Stimul. 2018;11 (2):435-444. doi: 10.1016/j.brs.2017.11.012. PubMed PMID:29246746 .

Milosevic, L, Kalia, SK, Hodaie, M, Lozano, AM, Fasano, A, Popovic, MR et al.. Neuronal inhibition and synaptic plasticity of basal ganglia neurons in Parkinson's disease. Brain. 2018;141 (1):177-190. doi: 10.1093/brain/awx296. PubMed PMID:29236966 PubMed Central PMC5917776.

Ghahremani, A, Wessel, JR, Udupa, K, Neagu, B, Zhuang, P, Saha, U et al.. Stopping and slowing manual and spoken responses: Similar oscillatory signatures recorded from the subthalamic nucleus. Brain Lang. 2018;176 :1-10. doi: 10.1016/j.bandl.2017.10.009. PubMed PMID:29125966 .

Basha, D, Dostrovsky, JO, Kalia, SK, Hodaie, M, Lozano, AM, Hutchison, WD et al.. Gamma oscillations in the somatosensory thalamus of a patient with a phantom limb: case report. J Neurosurg. 2018;129 (4):1048-1055. doi: 10.3171/2017.5.JNS17170. PubMed PMID:29125416 .

King, NKK, Krishna, V, Sammartino, F, Bari, A, Reddy, GD, Hodaie, M et al.. Anatomic Targeting of the Optimal Location for Thalamic Deep Brain Stimulation in Patients with Essential Tremor. World Neurosurg. 2017;107 :168-174. doi: 10.1016/j.wneu.2017.07.136. PubMed PMID:28774764 .

Lozano, AM, Hutchison, WD, Kalia, SK. What Have We Learned About Movement Disorders from Functional Neurosurgery?. Annu Rev Neurosci. 2017;40 :453-477. doi: 10.1146/annurev-neuro-070815-013906. PubMed PMID:28772097 .

Jitkritsadakul, O, Bhidayasiri, R, Kalia, SK, Hodaie, M, Lozano, AM, Fasano, A et al.. Systematic review of hardware-related complications of Deep Brain Stimulation: Do new indications pose an increased risk?. Brain Stimul. 2017;10 (5):967-976. doi: 10.1016/j.brs.2017.07.003. PubMed PMID:28739219 .

Mansouri, A, Taslimi, S, Badhiwala, JH, Witiw, CD, Nassiri, F, Odekerken, VJJ et al.. Deep brain stimulation for Parkinson's disease: meta-analysis of results of randomized trials at varying lengths of follow-up. J Neurosurg. 2018;128 (4):1199-1213. doi: 10.3171/2016.11.JNS16715. PubMed PMID:28665252 .

Yeoh, TY, Manninen, P, Kalia, SK, Venkatraghavan, L. In reply: Parkinsonism-hyperthermia syndrome and deep brain stimulation. Can J Anaesth. 2017;64 (6):677. doi: 10.1007/s12630-017-0838-8. PubMed PMID:28197981 .

Yeoh, TY, Manninen, P, Kalia, SK, Venkatraghavan, L. Anesthesia considerations for patients with an implanted deep brain stimulator undergoing surgery: a review and update. Can J Anaesth. 2017;64 (3):308-319. doi: 10.1007/s12630-016-0794-8. PubMed PMID:28028671 .

Sammartino, F, Krishna, V, Sankar, T, Fisico, J, Kalia, SK, Hodaie, M et al.. 3-Tesla MRI in patients with fully implanted deep brain stimulation devices: a preliminary study in 10 patients. J Neurosurg. 2017;127 (4):892-898. doi: 10.3171/2016.9.JNS16908. PubMed PMID:28009238 .

Beaulieu-Boire, I, Aquino, CC, Fasano, A, Poon, YY, Fallis, M, Lang, AE et al.. Deep Brain Stimulation in Rare Inherited Dystonias. Brain Stimul. 2016;9 (6):905-910. doi: 10.1016/j.brs.2016.07.009. PubMed PMID:27743838 .

Samuel, N, Bernstein, M, Alotaibi, NM, Kalia, SK, Shamji, MF. Patient Perspectives Regarding Ethics of Spinal Column Stimulators in the Surgical Management of Persistent Postoperative Neuropathic Pain. Neuromodulation. 2017;20 (3):274-278. doi: 10.1111/ner.12470. PubMed PMID:27491346 .

Wessel, JR, Ghahremani, A, Udupa, K, Saha, U, Kalia, SK, Hodaie, M et al.. Stop-related subthalamic beta activity indexes global motor suppression in Parkinson's disease. Mov Disord. 2016;31 (12):1846-1853. doi: 10.1002/mds.26732. PubMed PMID:27474845 PubMed Central PMC5154922.

Sammartino, F, Rowland, N, Hodaie, M, Kalia, SK, Lozano, AM, Hamani, C et al.. Diffusion tensor imaging and deep brain stimulation. Expert Rev Med Devices. 2016;13 (7):615-7. doi: 10.1080/17434440.2016.1195259. PubMed PMID:27232080 .

Alotaibi, NM, Ibrahim, GM, Jalal, H, Perez-Ordonez, B, Hodaie, M, Kalia, SK et al.. Subdural Collection as Initial Presentation of Granulomatosis With Polyangiitis. JAMA Neurol. 2016;73 (5):602-3. doi: 10.1001/jamaneurol.2015.4710. PubMed PMID:26998710 .

Honey, CR, Hamani, C, Kalia, SK, Sankar, T, Picillo, M, Munhoz, RP et al.. Deep Brain Stimulation Target Selection for Parkinson's Disease. Can J Neurol Sci. 2017;44 (1):3-8. doi: 10.1017/cjn.2016.22. PubMed PMID:26976064 .

Gondard, E, Chau, HN, Mann, A, Tierney, TS, Hamani, C, Kalia, SK et al.. Rapid Modulation of Protein Expression in the Rat Hippocampus Following Deep Brain Stimulation of the Fornix. Brain Stimul. 2015;8 (6):1058-64. doi: 10.1016/j.brs.2015.07.044. PubMed PMID:26321354 .

Kalia, LV, Kalia, SK, Lang, AE. Disease-modifying strategies for Parkinson's disease. Mov Disord. 2015;30 (11):1442-50. doi: 10.1002/mds.26354. PubMed PMID:26208210 .

Kalia, LV, Kalia, SK. α-Synuclein and Lewy pathology in Parkinson's disease. Curr Opin Neurol. 2015;28 (4):375-81. doi: 10.1097/WCO.0000000000000215. PubMed PMID:26110807 .

Krishna, V, Elias, G, Sammartino, F, Basha, D, King, NK, Fasano, A et al.. The effect of dexmedetomidine on the firing properties of STN neurons in Parkinson's disease. Eur J Neurosci. 2015;42 (4):2070-7. doi: 10.1111/ejn.13004. PubMed PMID:26108432 .

Sidiropoulos, C, Mestre, T, Hutchison, W, Moro, E, Valencia, A, Poon, YY et al.. Bilateral pallidal stimulation for sargoglycan epsilon negative myoclonus. Parkinsonism Relat Disord. 2014;20 (8):915-8. doi: 10.1016/j.parkreldis.2014.04.017. PubMed PMID:24812007 .

Sidiropoulos, C, Masani, K, Mestre, T, Milosevic, M, Poon, YY, Fallis, M et al.. Spinal cord stimulation for gait impairment in spinocerebellar ataxia 7. J Neurol. 2014;261 (3):570-4. doi: 10.1007/s00415-013-7236-0. PubMed PMID:24390202 .

Strauss, I, Kalia, SK, Lozano, AM. Where are we with surgical therapies for Parkinson's disease?. Parkinsonism Relat Disord. 2014;20 Suppl 1 :S187-91. doi: 10.1016/S1353-8020(13)70044-0. PubMed PMID:24262178 .

Kalia, SK, Sankar, T, Lozano, AM. Deep brain stimulation for Parkinson's disease and other movement disorders. Curr Opin Neurol. 2013;26 (4):374-80. doi: 10.1097/WCO.0b013e3283632d08. PubMed PMID:23817213 .

Kalia, SK, Lozano, AM. Parkinson disease: Neurostimulation in PD--benefit of early surgery revealed. Nat Rev Neurol. 2013;9 (5):244-5. doi: 10.1038/nrneurol.2013.66. PubMed PMID:23588359 .

Sidiropoulos, C, Hutchison, W, Mestre, T, Moro, E, Prescott, IA, Mizrachi, AV et al.. Bilateral pallidal stimulation for Wilson's disease. Mov Disord. 2013;28 (9):1292-5. doi: 10.1002/mds.25446. PubMed PMID:23554137 .

Matouk, CC, Ellis, MJ, Kalia, SK, Ginsberg, HJ. Skull fracture secondary to application of a Mayfield skull clamp in an adult patient: case report and review of the literature. Clin Neurol Neurosurg. 2012;114 (6):776-8. doi: 10.1016/j.clineuro.2011.12.036. PubMed PMID:22261664 .

Lozano, AM, Kalia, SK. New movement in Parkinson's. Sci Am. 2005;293 (1):68-75. doi: 10.1038/scientificamerican0705-68. PubMed PMID:16008304 .

Kim, RH, Smith, PD, Aleyasin, H, Hayley, S, Mount, MP, Pownall, S et al.. Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. Proc Natl Acad Sci U S A. 2005;102 (14):5215-20. doi: 10.1073/pnas.0501282102. PubMed PMID:15784737 PubMed Central PMC555037.

Kalia, SK, Lee, S, Smith, PD, Liu, L, Crocker, SJ, Thorarinsdottir, TE et al.. BAG5 inhibits parkin and enhances dopaminergic neuron degeneration. Neuron. 2004;44 (6):931-45. doi: 10.1016/j.neuron.2004.11.026. PubMed PMID:15603737 .

Kalia, SK, Nash, JE, Lozano, AM. To serve and protect? Interventions in the subthalamic nucleus for Parkinson's disease. Commentary on "Ablation of the subthalamic nucleus protects dopaminergic phenotype but not cell survival in a rat model of Parkinson's disease". Exp Neurol. 2004;185 (2):201-3. doi: 10.1016/j.expneurol.2003.10.005. PubMed PMID:14736500 .

Liu, L, Hsu, SS, Kalia, SK, Lozano, AM. Injury and strain-dependent dopaminergic neuronal degeneration in the substantia nigra of mice after axotomy or MPTP. Brain Res. 2003;994 (2):243-52. doi: 10.1016/j.brainres.2003.09.066. PubMed PMID:14642650 .

Search PubMed

Kalia Labs

Affiliations